The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
Kotani, M., Detheux, M., Vandenbogaerde, A., Communi, D., Vanderwinden, J.-M., Le Poul, E., Brézillon, S., Tyldesley, R., Suarez-Huerta, N., Vandeput, F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104847200 · Cited by 1,546
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Structural diversity of G protein-coupled receptors and significance for drug discovery
Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,492
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Neves, S. R., Ram, P. T., & Iyengar, R. (2002) · Science · doi:10.1126/science.1071550 · Cited by 1,286
Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., Suda, M., Koh, T., Natsui, K., Toyooka, S., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4753 · Cited by 1,284
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1083 · Cited by 1,177 · cited 1×
“Exenatide is given subcutaneously twice a day and has been shown to efficiently reduce glycated haemoglobin A1c (HbA1c) levels when added to on-going treatment with metformin, sulphonylurea or in triple therapy with sulphonylurea plus metformi”
BackgroundObestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake
Zhang, J. V., Ren, P.-G., Avsian-Kretchmer, O., Luo, C.-W., Rauch, R., Klein, C., & Hsueh, A. J. W. (2005) · Science · doi:10.1126/science.1117255 · Cited by 1,165
Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
Pinton, P., Giorgi, C., Siviero, R., Zecchini, E., & Rizzuto, R. (2008) · Oncogene · doi:10.1038/onc.2008.308 · Cited by 1,157
Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1355 · Cited by 1,129
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097 · cited 1×
“However, the recently discovered association of depression with rimonabant used as an anti-obesity agent raises concerns over whether this approach is worth pursuin”
BackgroundDrucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61206-4 · Cited by 1,070
Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review
Inzucchi, S. E. (2002) · JAMA · doi:10.1001/jama.287.3.360 · Cited by 1,065
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Self-citationAschner, P., Kipnes, M. S., Lunceford, J. K., Sanchez, M., Mickel, C., Williams-Herman, D. E., & for the Sitagliptin Study 021 Group (2006) · Diabetes Care · doi:10.2337/dc06-0703 · Cited by 880
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Variants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A. U., Aulchenko, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.290 · Cited by 744
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742
Scheen, A. J., Finer, N., Hollander, P., Jensen, M. D., & Van Gaal, L. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 736
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetologia · doi:10.1007/s00125-008-1157-y · Cited by 712
Klonoff, D. C., Buse, J. B., Nielsen, L. L., Guan, X., Bowlus, C. L., Holcombe, J. H., Wintle, M. E., & Maggs, D. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x253870 · Cited by 699
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Doyle, M. E., & Egan, J. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.007 · Cited by 680
Nauck, M. A., Meininger, G., Sheng, D., Terranella, L., Stein, P. P., & Sitagliptin Study 024 Group (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00704.x · Cited by 667
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664 · cited 1×
“For example, it has been shown that activating GLP1 and glucose-dependent insulinotropic polypeptide (GIP) receptors increases β-cell mass in rodent islets through stimulating islet neogenesis and inhibiting apoptosi”
BackgroundOverton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C. T., Gardner, L. S., Griffin, G., Jackson, H. C., Procter, M. J., Rasamison, C. M., Tang-Christensen, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.004 · Cited by 655
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Stein, C. J., & Colditz, G. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0288 · Cited by 615
Bouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J.-P., Davenport, A. P., Spedding, M., & Harmar, A. J. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.5 · Cited by 592
Wess, J. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141501 · Cited by 589
Edfalk, S., Steneberg, P., & Edlund, H. (2008) · Diabetes · doi:10.2337/db08-0307 · Cited by 587
Ghrelin Is Present in Pancreatic α-Cells of Humans and Rats and Stimulates Insulin Secretion
Date, Y., Nakazato, M., Hashiguchi, S., Dezaki, K., Mondal, M. S., Hosoda, H., Kojima, M., Kangawa, K., Arima, T., Matsuo, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.1.124 · Cited by 574
Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
FEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528
Hermansen, K., Kipnes, M., Luo, E., Fanurik, D., Khatami, H., Stein, P., & Sitagliptin Study 035 Group (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00744.x · Cited by 525
T., V., T., K., S., M., & J., H. (2002) · Diabetologia · doi:10.1007/s00125-002-0878-6 · Cited by 518
GCRDb: a G-protein-coupled receptor database.
Kolakowski, L. F. (1994) · PubMed · Cited by 517
Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
Kojima, M., Hosoda, H., Matsuo, H., & Kangawa, K. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00362-3 · Cited by 516
Rosenstock, J., Brazg, R., Andryuk, P. J., Lu, K., & Stein, P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.007 · Cited by 514
Goldstein, B. J., Feinglos, M. N., Lunceford, J. K., Johnson, J., Williams-Herman, D. E., & for the Sitagliptin 036 Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0627 · Cited by 509
Ahrén, B., Gomis, R., Standl, E., Mills, D., & Schweizer, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2874 · Cited by 487
Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
Holst, J. J., & Deacon, C. F. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1663 · Cited by 487
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas
Wierup, N., Svensson, H., Mulder, H., & Sundler, F. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00067-8 · Cited by 457
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
Holst, B., Egerod, K. L., Schild, E., Vickers, S. P., Cheetham, S., Gerlach, L.-O., Storjohann, L., Stidsen, C. E., Jones, R., Beck-Sickinger, A. G., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0933 · Cited by 433
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
Prentki, M., Joly, E., El-Assaad, W., & Roduit, R. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s405 · Cited by 431
Kennedy, L. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79145-5 · Cited by 427
Højberg, P. V., Vilsbøll, T., Rabøl, R., Knop, F. K., Bache, M., Krarup, T., Holst, J. J., & Madsbad, S. (2009) · Diabetologia · doi:10.1007/s00125-008-1195-5 · Cited by 414
Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D., & Edlund, H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.007 · Cited by 411
Briscoe, C. P., Peat, A. J., McKeown, S. C., Corbett, D. F., Goetz, A. S., Littleton, T. R., McCoy, D. C., Kenakin, T. P., Andrews, J. L., Ammala, C., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706770 · Cited by 400
Chu, Z.-L., Carroll, C., Alfonso, J., Gutierrez, V., He, H., Lucman, A., Pedraza, M., Mondala, H., Gao, H., Bagnol, D., et al. (2008) · Endocrinology · doi:10.1210/en.2007-0966 · Cited by 387
Keller, M. P., Choi, Y., Wang, P., Belt Davis, D., Rabaglia, M. E., Oler, A. T., Stapleton, D. S., Argmann, C., Schueler, K. L., Edwards, S., et al. (2008) · Genome Research · doi:10.1101/gr.074914.107 · Cited by 377
Owens, D. R., Zinman, B., & Bolli, G. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05842-1 · Cited by 373
Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., Takasaki, J., Matsumoto, S.-I., Kamohara, M., Hiyama, H., Yoshida, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.120 · Cited by 367
Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice
Sun, Y., Asnicar, M., Saha, P. K., Chan, L., & Smith, R. G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.004 · Cited by 355
Volante, M., AllÌa, E., Gugliotta, P., Funaro, A., Broglio, F., Deghenghi, R., Muccioli, G., Ghigo, E., & Papotti, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8279 · Cited by 354
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs
Kotarsky, K., Nilsson, N. E., Flodgren, E., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03064-4 · Cited by 352
Dose-Dependent Inhibition by Ghrelin of Insulin Secretion in the Mouse
Reimer, M. K., Pacini, G., & Ahrén, B. (2003) · Endocrinology · doi:10.1210/en.2002-220819 · Cited by 316
Meier, J. J., Gallwitz, B., Siepmann, N., Holst, J. J., Deacon, C. F., Schmidt, W. E., & Nauck, M. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1103-y · Cited by 314
Melatonin, endocrine pancreas and diabetes
Peschke, E. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00519.x · Cited by 309
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
Rendell, M. (2004) · Drugs · doi:10.2165/00003495-200464120-00006 · Cited by 308
Gautam, D., Han, S.-J., Hamdan, F. F., Jeon, J., Li, B., Li, J. H., Cui, Y., Mears, D., Lu, H., Deng, C., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.009 · Cited by 299 · cited 1×
“Five muscarinic receptor subtypes exist, and the M3 subtype is of importance for the stimulation of insulin secretio”
BackgroundMcKee, K. K., Tan, C. P., Palyha, O. C., Liu, J., Feighner, S. D., Hreniuk, D. L., Smith, R. G., Howard, A. D., & Van der Ploeg, L. H. T. (1997) · Genomics · doi:10.1006/geno.1997.5069 · Cited by 296
Chu, Z.-L., Jones, R. M., He, H., Carroll, C., Gutierrez, V., Lucman, A., Moloney, M., Gao, H., Mondala, H., Bagnol, D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1608 · Cited by 294
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers, R., Maurice, P., Boutin, J. A., & Delagrange, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.184 · Cited by 293
Seven evolutionarily conserved human rhodopsin G protein‐coupled receptors lacking close relatives
Fredriksson, R., Höglund, P. J., Gloriam, D. E. I., Lagerström, M. C., & Schiöth, H. B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01196-7 · Cited by 292
The endocannabinoid system in obesity and type 2 diabetes
Di Marzo, V. (2008) · Diabetologia · doi:10.1007/s00125-008-1048-2 · Cited by 281
Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence
Diamant, M., & Heine, R. J. (2003) · Drugs · doi:10.2165/00003495-200363130-00004 · Cited by 277
Drucker, D. J. (2003) · Endocrinology · doi:10.1210/en.2003-1147 · Cited by 274
Alpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B. E., Foley, J. E., & Ahrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1878-0 · Cited by 271
Self-citationComparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
Rosenstock, J., Baron, M. A., Dejager, S., Mills, D., & Schweizer, A. (2007) · Diabetes Care · doi:10.2337/dc06-1815 · Cited by 270
Garber, A. J., Schweizer, A., Baron, M. A., Rochotte, E., & Dejager, S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00684.x · Cited by 268
The U.K. Prospective Diabetes Study. A review
Turner, R. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.c35 · Cited by 267
GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesity
Overton, H. A., Fyfe, M. C. T., & Reynet, C. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707529 · Cited by 264
Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion
Ahrén, B., Taborsky, G. J., & Porte, D. (1986) · Diabetologia · doi:10.1007/bf00870137 · Cited by 264
Self-citationEvidence for a circadian rhythm of insulin secretion
Boden, G., Ruiz, J., Urbain, J. L., & Chen, X. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.2.e246 · Cited by 261
The NPY/AgRP neuron and energy homeostasis
Morton, G., & Schwartz, M. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801915 · Cited by 261
GPR40 Is Necessary but Not Sufficient for Fatty Acid Stimulation of Insulin Secretion In Vivo
Latour, M. G., Alquier, T., Oseid, E., Tremblay, C., Jetton, T. L., Luo, J., Lin, D. C.-H., & Poitout, V. (2007) · Diabetes · doi:10.2337/db06-1532 · Cited by 259
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
Juan-Picó, P., Fuentes, E., Javier Bermúdez-Silva, F., Javier Díaz-Molina, F., Ripoll, C., Rodríguez de Fonseca, F., & Nadal, A. (2006) · Cell Calcium · doi:10.1016/j.ceca.2005.10.005 · Cited by 258
Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas
Tornehave, D., Kristensen, P., Rømer, J., Knudsen, L. B., & Heller, R. S. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951319 · Cited by 248
Madsen, K., Knudsen, L. B., Agersoe, H., Nielsen, P. F., Thøgersen, H., Wilken, M., & Johansen, N. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070861j · Cited by 244
Dezaki, K., Sone, H., Koizumi, M., Nakata, M., Kakei, M., Nagai, H., Hosoda, H., Kangawa, K., & Yada, T. (2006) · Diabetes · doi:10.2337/db06-0878 · Cited by 242
Schweizer, A., Couturier, A., Foley, J. E., & Dejager, S. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02191.x · Cited by 240
Trümper, A., Trümper, K., Trusheim, H., Arnold, R., Göke, B., & Hörsch, D. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.9.0688 · Cited by 238
Rosenstock, J., Sankoh, S., & List, J. F. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00876.x · Cited by 234
Probing cell type–specific functions of Gi in vivo identifies GPCR regulators of insulin secretion
Regard, J. B., Kataoka, H., Cano, D. A., Camerer, E., Yin, L., Zheng, Y.-W., Scanlan, T. S., Hebrok, M., & Coughlin, S. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32994 · Cited by 233
Garber, A. J., Foley, J. E., Banerji, M. A., Ebeling, P., Gudbjörnsdottir, S., Camisasca, R. ‐., Couturier, A., & Baron, M. A. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00859.x · Cited by 230
Ahren, B., & Pacini, G. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500097 · Cited by 229
Esler, W. P., Rudolph, J., Claus, T. H., Tang, W., Barucci, N., Brown, S.-E., Bullock, W., Daly, M., DeCarr, L., Li, Y., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0239 · Cited by 227
GLP-1 Receptor Agonists and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes
Ahrén, B., & Schmitz, O. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-826178 · Cited by 224
Self-citationIncretin-Based Therapies in Type 2 Diabetes Mellitus
Chia, C. W., & Egan, J. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2109 · Cited by 223
Glucagon receptors on human islet cells contribute to glucose competence of insulin release
Huypens, P., Ling, Z., Pipeleers, D., & Schuit, F. (2000) · Diabetologia · doi:10.1007/s001250051484 · Cited by 222
Insulin Signaling in the Pancreatic β-Cell
Leibiger, I. B., Leibiger, B., & Berggren, P.-O. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155530 · Cited by 220
The G protein-coupled receptor subset of the rat genome
Gloriam, D. E., Fredriksson, R., & Schiöth, H. B. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-338 · Cited by 213
Dipeptidyl Peptidase-4 Inhibitors
Ahrén, B. (2007) · Diabetes Care · doi:10.2337/dc07-0233 · Cited by 203
Skeletal consequences of thiazolidinedione therapy
Grey, A. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0477-y · Cited by 198
Matthews, J. E., Stewart, M. W., De Boever, E. H., Dobbins, R. L., Hodge, R. J., Walker, S. E., Holland, M. C., Bush, M. A., & for the Albiglutide Study Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1518 · Cited by 198
Neuropeptides and their receptors: innovative science providing novel therapeutic targets
Brain, S. D., & Cox, H. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706461 · Cited by 197
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High‐fat Diet
Starowicz, K. M., Cristino, L., Matias, I., Capasso, R., Racioppi, A., Izzo, A. A., & Di Marzo, V. (2008) · Obesity · doi:10.1038/oby.2007.106 · Cited by 194
Bolli, G., Dotta, F., Rochotte, E., & Cohen, S. E. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00820.x · Cited by 192
Presence of functional cannabinoid receptors in human endocrine pancreas
Bermúdez-Silva, F. J., Suárez, J., Baixeras, E., Cobo, N., Bautista, D., Cuesta-Muñoz, A. L., Fuentes, E., Juan-Pico, P., Castro, M. J., Milman, G., et al. (2008) · Diabetologia · doi:10.1007/s00125-007-0890-y · Cited by 191
Purinergic and pyrimidinergic receptors as potential drug targets
Williams, M., & Jarvis, M. F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00341-x · Cited by 191
Jamen, F., Persson, K., Bertrand, G., Rodriguez-Henche, N., Puech, R., Bockaert, J., Ahrén, B., & Brabet, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9387 · Cited by 190
Self-citationLaburthe, M., Couvineau, A., & Tan, V. (2007) · Peptides · doi:10.1016/j.peptides.2007.04.026 · Cited by 189
G-protein-coupled receptors and islet function—Implications for treatment of type 2 diabetes
Winzell, M. S., & Ahrén, B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.002 · Cited by 183
Self-citationHeller, R. S., Kieffer, T. J., & Habener, J. F. (1997) · Diabetes · doi:10.2337/diab.46.5.785 · Cited by 179
Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis
Dezaki, K., Sone, H., & Yada, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.008 · Cited by 177
A role for kisspeptin in islet function
Hauge-Evans, A. C., Richardson, C. C., Milne, H. M., Christie, M. R., Persaud, S. J., & Jones, P. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0343-z · Cited by 171
The Fatty Acid Receptor GPR40 Plays a Role in Insulin Secretion In Vivo After High-Fat Feeding
Kebede, M., Alquier, T., Latour, M. G., Semache, M., Tremblay, C., & Poitout, V. (2008) · Diabetes · doi:10.2337/db08-0553 · Cited by 169
Gremlich, S., Porret, A., Hani, E. H., Cherif, D., Vionnet, N., Froguel, P., & Thorens, B. (1995) · Diabetes · doi:10.2337/diab.44.10.1202 · Cited by 166
Altered Gastrointestinal and Metabolic Function in the GPR39-Obestatin Receptor–Knockout Mouse
Moechars, D., Depoortere, I., Moreaux, B., de Smet, B., Goris, I., Hoskens, L., Daneels, G., Kass, S., Ver Donck, L., Peeters, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.009 · Cited by 165
Tan, C. P., Feng, Y., Zhou, Y.-P., Eiermann, G. J., Petrov, A., Zhou, C., Lin, S., Salituro, G., Meinke, P., Mosley, R., et al. (2008) · Diabetes · doi:10.2337/db08-0130 · Cited by 163
Allosteric modulation of heterodimeric G-protein-coupled receptors
Milligan, G., & Smith, N. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.001 · Cited by 162
Normal Control of Growth Hormone Secretion
Hartman, M. L., Veldhuis, J. D., & Thorner, M. O. (1993) · Hormone Research · doi:10.1159/000183766 · Cited by 161
The Role of Long-Chain Fatty Acyl-CoA Esters in β-Cell Signal Transduction
Corkey, B. E., Deeney, J. T., Yaney, G. C., Tornheim, K., & Prentki, M. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.299s · Cited by 161
Melatonin and type 2 diabetes – a possible link?*
Peschke, E., Stumpf, I., Bazwinsky, I., Litvak, L., Dralle, H., & Mühlbauer, E. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00426.x · Cited by 161
Jeandrot, A., Richard, J.-L., Combescure, C., Jourdan, N., Finge, S., Rodier, M., Corbeau, P., Sotto, A., & Lavigne, J.-P. (2008) · Diabetologia · doi:10.1007/s00125-007-0840-8 · Cited by 160
Free Fatty Acid Receptors and Drug Discovery
Hirasawa, A., Hara, T., Katsuma, S., Adachi, T., & Tsujimoto, G. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1847 · Cited by 159
New hepatic targets for glycaemic control in diabetes
Agius, L. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.001 · Cited by 155
A Family of Fatty Acid Binding Receptors
Brown, A. J., Jupe, S., & Briscoe, C. P. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.54 · Cited by 151
Salehi, A., Flodgren, E., Nilsson, N. E., Jimenez-Feltstrom, J., Miyazaki, J., Owman, C., & Olde, B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0017-z · Cited by 150
Semple, G., Fioravanti, B., Pereira, G. R., Calderon, I., Uy, J., Choi, K., Xiong, Y., Ren, A., Morgan, M. E., Davé, V., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006867 · Cited by 144
Type 2 Diabetes, Insulin Secretion and β-Cell Mass
Ahren, B. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766004 · Cited by 143
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
Russell-Jones, D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.018 · Cited by 137
Baggio, L. L., Huang, Q., Cao, X., & Drucker, D. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.017 · Cited by 137
Glucagon-like peptide-1 (GLP-1): A gut hormone of potential interest in the treatment of diabetes
Åhrén, B. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199808)20:8<642::aid-bies7>3.0.co;2-k · Cited by 136
Pathways in Beta-Cell Stimulus-Secretion Coupling as Targets for Therapeutic Insulin Secretagogues
Henquin, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s48 · Cited by 136
Brand, C. L., Rolin, B., Jørgensen, P. N., Svendsen, I., Kristensen, J. S., & Holst, J. J. (1994) · Diabetologia · doi:10.1007/bf00400461 · Cited by 135
Morphological analysis of ghrelin and its receptor distribution in the rat pancreas
Kageyama, H., Funahashi, H., Hirayama, M., Takenoya, F., Kita, T., Kato, S., Sakurai, J., Lee, E. Y., Inoue, S., Date, Y., et al. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.031 · Cited by 132
Piteau, S., Olver, A., Kim, S.-J., Winter, K., Pospisilik, J. A., Lynn, F., Manhart, S., Demuth, H.-U., Speck, M., Pederson, R. A., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.115 · Cited by 130
Peschke, E., Peschke, D., Hammer, T., & CSERNUS, V. J. (1997) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1997.tb00349.x · Cited by 125
Reduction in Voltage-Gated K+ Currents in Primary Cultured Rat Pancreatic β-Cells by Linoleic Acids
Feng, D. D., Luo, Z., Roh, S.-G., Hernandez, M., Tawadros, N., Keating, D. J., & Chen, C. (2006) · Endocrinology · doi:10.1210/en.2005-0225 · Cited by 124
Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function
Sørensen, H., Winzell, M. S., Brand, C. L., Fosgerau, K., Gelling, R. W., Nishimura, E., & Åhrén, B. (2006) · Diabetes · doi:10.2337/db06-0307 · Cited by 123
Kemp, D. M., Ubeda, M., & Habener, J. F. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00064-3 · Cited by 122
Picinato, M. C., Haber, E. P., Cipolla‐Neto, J., Curi, R., Carvalho, C. R. D. O., & Carpinelli, Â. R. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.02903.x · Cited by 121
Tanaka, T., Yano, T., Adachi, T., Koshimizu, T., Hirasawa, A., & Tsujimoto, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0250-y · Cited by 120
Mead, E. J., Maguire, J. J., Kuc, R. E., & Davenport, A. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707295 · Cited by 117
GPCR deorphanizations: the novel, the known and the unexpected transmitters
Civelli, O. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.005 · Cited by 117
The pathogenesis of NIDDM involves a defective expression of the GIP receptor
Holst, J. J., Gromada, J., & Nauck, M. A. (1997) · Diabetologia · doi:10.1007/s001250050779 · Cited by 116
de Heer, J., & Holst, J. J. (2007) · Diabetes · doi:10.2337/db06-0738 · Cited by 115
Nakata, M., & Yada, T. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.009 · Cited by 114
Fonseca, V. A. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002351 · Cited by 114
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors
Pratley, R. E., & Gilbert, M. P. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.73 · Cited by 113
Neuropeptide Y receptors; antisecretory control of intestinal epithelial function
Cox, H. M. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.10.005 · Cited by 111
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats
Bermúdez‐Silva, F. J., Serrano, A., Diaz-Molina, F. J., Sánchez-Vera, I., Juan-Picó, P., Nadal, Á., Fuentes, E., & de Fonseca, F. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.016 · Cited by 109
GPR40 is expressed in glucagon producing cells and affects glucagon secretion
Flodgren, E., Olde, B., Abaraviciene, S. M., Winzell, M. S., Åhrén, B., & Salehi, A. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.193 · Cited by 106
Asnicar, M., Koster, A. M., Heiman, M. L., Tinsley, F. C., Smith, D. P., Galbreath, E. J., Fox, N. W., Ma, Y. L., Blum, W. F., & Hsiung, H. M. (2002) · Endocrinology · doi:10.1210/en.2002-220354 · Cited by 104
Chanoine, J., & Wong, A. C. K. (2004) · Endocrinology · doi:10.1210/en.2004-0053 · Cited by 104
Purinergic receptors in the endocrine and exocrine pancreas
Novak, I. (2007) · Purinergic Signalling · doi:10.1007/s11302-007-9087-6 · Cited by 101
Sakamoto, Y., Inoue, H., Kawakami, S., Miyawaki, K., Miyamoto, T., Mizuta, K., & Itakura, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.076 · Cited by 101
Tomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0193-8 · Cited by 99
Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice
Peterhoff, M., Sieg, A., Brede, M., Chao, C., Hein, L., & Ullrich, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490343 · Cited by 98
Molecular Mechanisms of β2-Adrenergic Receptor Function and Regulation
McGraw, D. W., & Liggett, S. B. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-027sr · Cited by 95
Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
Åhrén, B. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802584126 · Cited by 95
Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets
Kieffer, T. J., Heller, R. S., Unson, C. G., Weir, G. C., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895386 · Cited by 94
Antidiabetogenic Action of Cholecystokinin-8 in Type 2 Diabetes
Åhrén, B., Holst, J. J., & Efendić, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6431 · Cited by 92
Filipsson, K., Tornøe, K., Holst, J., & Ahrén, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4230 · Cited by 91
Hussein, Z. B., Wentworth, J. M., Nankervis, A. J., Proietto, J., & Colman, P. G. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06441.x · Cited by 88
Xie, S., Furjanic, M. A., Ferrara, J., McAndrew, N. R., Ardino, E. L., Ngondara, A., Bernstein, Y., Thomas, K. J., Kim, E., Walker, J. M., et al. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00817.x · Cited by 84
Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
Åhrén, B. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1944 · Cited by 84
Berna, M. J., Tapia, J. A., Sancho, V., & Jensen, R. T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.09.011 · Cited by 83
The Neuropeptide Pituitary Adenylate Cyclase–Activating Polypeptide and Islet Function
Filipsson, K., Reimer, M. K., & Åhrén, B. (2001) · Diabetes · doi:10.2337/diabetes.50.9.1959 · Cited by 81
Morgan, D. G., Kulkarni, R. N., Hurley, J. D., Wang, Z. L., Wang, R. M., Ghatei, M. A., Karlsen, A. E., Bloom, S. R., & Smith, D. M. (1998) · Diabetologia · doi:10.1007/s001250051095 · Cited by 79
Role of the M 3 muscarinic acetylcholine receptor in β‐cell function and glucose homeostasis
Gautam, D., Han, S. J., Duttaroy, A., Mears, D. J., Hamdan, F. F., Li, J. H., Cui, Y., Jeon, J., & Wess, J. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00781.x · Cited by 78
Gedulin, B. R., Smith, P., Prickett, K. S., Tryon, M. S., Barnhill, S. D., Reynolds, J., Nielsen, L. L., Parkes, D. G., & Young, A. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1795-2 · Cited by 77
Broadstone, V. L., Pfeifer, M. A., Bajaj, V. R., Stagner, J. I., & Samols, E. (1987) · Diabetes · doi:10.2337/diab.36.8.932 · Cited by 77
Mühlbauer, E., & Peschke, E. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00399.x · Cited by 76
β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance
Åhrén, B. (2008) · Diabetes · doi:10.2337/db08-1158 · Cited by 76
Neuropeptides and the Regulation of Islet Function
Åhrén, B., Wierup, N., & Sundler, F. (2006) · Diabetes · doi:10.2337/db06-s013 · Cited by 72
Flatt, P. R. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02455.x · Cited by 68
Winzell, M. S., Brand, C. L., Wierup, N., Sidelmann, U. G., Sundler, F., Nishimura, E., & Åhrén, B. (2007) · Diabetologia · doi:10.1007/s00125-007-0675-3 · Cited by 68
Parker, E. M. (2004) · Elsevier eBooks · doi:10.1016/b0-12-443710-9/00422-1 · Cited by 68
The islet enhancer vildagliptin: mechanisms of improved glucose metabolism
Åhrén, B., & Foley, J. E. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01685.x · Cited by 67
Neuropeptide Y promotes β-cell replication via extracellular signal-regulated kinase activation
Cho, Y. R., & Kim, C. W. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.170 · Cited by 67
Vettor, R., Granzotto, M., Stefani, D. D., Trevellin, E., Rossato, M., Farina, M. G., Milan, G., Pilon, C., Nigro, A., Federspil, G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2680 · Cited by 67
Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes
Deacon, C. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.533 · Cited by 66
Larsson, H. E., & Åhrén, B. (2000) · Diabetologia · doi:10.1007/s001250050029 · Cited by 65
Glucagon as a target for the treatment of Type 2 diabetes
Sloop, K. W., Michael, M. D., & Moyers, J. S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.593 · Cited by 64
Endocrine pancreas and diabetes
Hales, C. N. (1980) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(80)90087-0 · Cited by 64
G-protein coupled receptor structure
Yèagle, P. L., & Albert, A. D. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.10.002 · Cited by 64
Fischer, B., Chulkin, A., Boyer, J. L., Harden, K. T., Gendron, F., Beaudoin, A. R., Chapal, J., Hillaire‐Buys, D., & Petit, P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990158y · Cited by 63
Silvestre, R. A., Egido, E. M., Hernández, R., & Marco, J. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0454 · Cited by 63
GPR119: “Double-Dipping” for Better Glycemic Control
Lauffer, L., Iakoubov, R., & Brubaker, P. L. (2008) · Endocrinology · doi:10.1210/en.2008-0182 · Cited by 62
Kowluru, A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00196.2003 · Cited by 62
Purinergic receptors on insulin‐secreting cells
Hillaire‐Buys, D., Chapal, J., Bertrand, G., Petit, P., & Loubatières-Mariani, M.-M. (1994) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1994.tb00788.x · Cited by 59
Drugs on the horizon for diabesity
Bailey, C. J. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0093-1 · Cited by 55
Cholecystokinin and the Regulation of Insulin Secretion
Karlsson, S., & Åhrén, B. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529208999942 · Cited by 55
Cited by
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
Albumin as a versatile platform for drug half-life extension
Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 485
A chemical-genetic approach to study G protein regulation of β cell function in vivo
Guettier, J.-M., Gautam, D., Scarselli, M., de Azua, I. R., Li, J. H., Rosemond, E., Ma, X., Gonzalez, F. J., Armbruster, B. N., Lu, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906593106 · Cited by 344
Metadata
- Authors
- Ahrén, B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-04-14
- Volume
- 8
- Issue
- 5
- Pages
- 369-385
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2094177994
- Cited by
- 419
- References
- 234
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.